Virginia Acha: insights on industry

In this video interview, filmed at Lilly’s Erl Wood at 50 celebration event, Virginia Acha (then Association of the British Pharmaceutical Industry (ABPI)) shares her thoughts on research and development in the UK, the main challenges in this area, and the core innovation priorities for the UK in coming decades.
Dr Virginia Acha was the Executive Director Research, Medical and Innovation at ABPI until late 2017 and had responsibility for driving the agenda for innovation in the UK. Dr Acha previously worked for Amgen as Director, Global Regulatory and R&D Policy – Europe, Middle East and Africa. She holds the chair for the Pharmacovigilance working group in the IFPMA Biotherapeutics Committee, and until recently was the Vice-Chair for the European Biopharmaceutical Enterprises (EBE) Biosimilars Task Force and the lead for the EFPIA Regulatory Network supporting Turkey. Previously, she spent nearly 5 years at Pfizer working on policy development and engagement in a number of domains, including science, innovation and access and choice in healthcare.

This content has been financially supported by Lilly.